Thomas J. Schall - 27 Jun 2025 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Thomas J. Schall
Issuer symbol
IMRX
Transactions as of
27 Jun 2025
Net transactions value
+$34,788
Form type
4
Filing time
30 Jun 2025, 09:09:20 UTC
Previous filing
18 Jun 2025
Next filing
20 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schall Thomas J. Director C/O IMMUNEERING CORPORATION, 245 MAIN STREET, 2ND FLOOR, CAMBRIDGE /s/ Michael D. Bookman, Attorney-in-Fact for Thomas J. Schall 30 Jun 2025 0001423084

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $34,788 +9,500 +22% $3.66 52,885 27 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.6 to $3.73. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.